CD74 (along with CD44) was demonstrated to be responsible for MIF liberation of angiogenic factors in vitro, ref. [25] and our in vivo studies in humans as well as a baboon model for endometriosis [30] demonstrate that CD74 is robustly expressed in endometriotic lesion tissue. The gene discussed is CD44; the disease is endometriosis.